NEW2026 · Text us +1 272-529-4722
The most widely prescribed treatment for osteoporosis and bone-density loss.
Reviewed by:
Dr. Steve Malen, PharmD
Dr. Steven Blikstein, PharmD
Strength
How would you like to get this medication?
Choose a strength and quantity to continue.
Alendronate is a prescription medication used to treat and prevent osteoporosis in postmenopausal women and men, as well as to treat Paget’s disease of bone. As a bisphosphonate, it slows bone loss and increases bone density, helping to prevent fractures. By inhibiting osteoclast activity (the cells that break down bone), alendronate helps strengthen bones and maintain their structure over time. It is available by prescription only and should be taken exactly as directed.
Complete a health screening
A short questionnaire about your health history and current symptoms — takes about 2 minutes.
Provider reviews your answers
A licensed provider reviews your screening answers, typically within 24 hours.
Prescription fulfilled
If approved, your Rx is sent to Invictus Pharmacy and you're notified by text or email. Free nationwide shipping.
Important safety information
Fosamax is not suitable for all individuals, and specific contraindications must be taken into account before starting the medication.
Fosamax is contraindicated in patients with specific esophageal abnormalities, such as esophageal narrowing, or other conditions that affect their ability to swallow. Such conditions pose a risk of esophageal irritation or ulcers, as Fosamax must pass smoothly into the stomach without lingering in the esophagus.
People who cannot remain upright for at least 30 minutes after taking the medication also should not use Fosamax. This requirement is crucial to prevent esophageal irritation and ensure the medication reaches the stomach for proper absorption.
Additionally, patients with significant renal impairment are advised against using Fosamax. This is due to the drug’s renal excretion pathway, which might be compromised in individuals with severe kidney conditions, affecting the drug’s clearance and leading to accumulation and possible toxicity.
Fosamax should be used cautiously, if at all, in women who are pregnant or breastfeeding. Given the limited data on its safety in these populations, healthcare professionals generally recommend alternative treatments.
All known allergies to Fosamax or any of its components should be communicated before starting treatment to rule out hypersensitivity reactions.
Alendronate is a medication in the bisphosphonate class used to treat and prevent bone loss. It works by preventing osteoclasts —the cells responsible for bone resorption—from breaking down bone tissue. This helps maintain the balance between bone formation and bone resorption, thereby strengthening bones and reducing fracture risk in conditions such as osteoporosis.
Alendronate is commonly prescribed as part of a broader treatment strategy that may also include lifestyle measures such as adequate calcium and vitamin D intake, weight-bearing exercise, and fall prevention. When used correctly and consistently, it plays an important role in preserving bone density and skeletal strength.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
Fosamax and Binosto are brand-name formulations of alendronate, each delivering the same active ingredient in different dosage forms. Fosamax is available as standard oral tablets and an oral solution, whereas Binosto is formulated as an effervescent tablet that dissolves in water before ingestion, providing an alternative for patients who have difficulty swallowing tablets.
Although both medications contain alendronate and work through the same mechanism to reduce bone resorption, their formulations may affect ease of use, tolerability, and adherence. Understanding the differences between Fosamax and Binosto allows patients and healthcare providers to select the formulation that best aligns with individual needs, preferences, and administration requirements.
Fosamax is a medication primarily used to treat bone-related conditions by increasing bone mass and reducing fracture risk. It is widely prescribed to help individuals manage several specific conditions.
For these conditions, alendronate not only strengthens bones but also, in some cases, promotes actual bone healing and bone tissue remodeling. By preventing excessive bone breakdown, Fosamax reduces the risk of fractures, which are often serious and can significantly impair quality of life.
Understanding Fosamax’s mechanism of action provides insight into how it effectively manages various bone disorders. As a bisphosphonate, Fosamax fundamentally influences the bone remodeling cycle, a continuous process in the body that involves bone formation and resorption.
Fosamax’s primary action is to inhibit osteoclast activity. Osteoclasts are the cells responsible for bone resorption, a component of the natural process of bone turnover. By reducing osteoclast-mediated bone breakdown, Fosamax allows osteoblasts—the bone-forming cells—to work more effectively to maintain or increase bone density.
This inhibition results in net gains in bone mineral density, subsequently leading to stronger bones and decreased fracture risk. In conditions like osteoporosis, where bone resorption outpaces formation, this action is particularly beneficial.
After administration, Fosamax is absorbed and binds strongly to the bone mineral matrix, where it remains active by inhibiting osteoclast function, providing an extended duration of action.
Following adherence to bone, its effects can last for weeks or months, making the medication effective even after stopping treatment. However, the oral absorption rate is relatively low, necessitating specific administration instructions to maximize efficacy.
Patients benefit from this long half-life, as it contributes to sustained improvements in bone density with consistent dosing over time. The extended action also aligns with its once-weekly dosing schedule for osteoporosis, providing both convenience and consistent therapeutic effect.
The dosage and administration of Fosamax require careful attention to achieve optimal therapeutic outcomes while minimizing potential side effects. Healthcare providers personalize dosing schedules based on individual patient needs and specific conditions being treated.
For osteoporosis treatment and prevention, Fosamax is typically prescribed at 70 mg once weekly. This standard dose aims to ensure consistent suppression of osteoclast activity.
For the treatment of Paget’s disease, dosing may vary and may be higher; however, the specific regimen should always be followed as directed by a healthcare provider.
Fosamax’s ability to remain effective even when temporarily discontinued is an advantage; however, adherence to the prescribed dosing schedule is important to maintain bone density gains.
Proper administration is critical to maximize absorption and effectiveness. Fosamax should be taken first thing in the morning, ideally upon waking, with a full glass of water. The medication should be taken at least 30 minutes before any food, drinks (other than plain water), or other medications to improve absorption, which is crucial given its low oral bioavailability.
Additionally, it is essential to stay upright—either sitting or standing—for at least 30 minutes after taking Fosamax. This action helps prevent any esophageal irritation or ulceration risk and enhances absorption efficiency.
Patients are advised to follow their healthcare professional’s instructions closely and to discuss any concerns or unusual symptoms they encounter.
Fosamax, like all medications, may lead to various side effects. While it is effective in treating bone conditions, understanding its potential side effects allows patients to monitor their well-being and address concerns promptly.
The most frequently reported side effects involve the digestive and musculoskeletal systems:
Occasionally, patients report fatigue, headache, or mild flu-like symptoms, especially after the first dose. These effects are usually short-lived and manageable with supportive care.
Though uncommon, serious adverse effects can occur and warrant medical evaluation:
Fosamax can interact with several commonly consumed substances, thereby reducing its absorption due to its low oral bioavailability.
Monitoring and discussing all medications, including over-the-counter drugs and supplements, with a healthcare provider can help prevent adverse reactions.
Administration & Dosage
Fosamax should be taken orally first thing in the morning with a full glass of water, at least 6 to 8 ounces. To ensure maximum absorption and minimize potential gastrointestinal side effects, it is vital to remain upright for at least 30 minutes after taking the medication. Avoid lying down until after your first meal of the day. Do not eat, drink anything other than water, or take any other medications during these 30 minutes.
Fosamax is most effective when taken first thing in the morning. Its absorption can be significantly decreased if taken later in the day or after consuming food or beverages other than water. For this reason, it is not recommended to take Fosamax in the afternoon. Consistency in timing helps maintain the optimal caution needed to prevent complications, especially those related to esophageal irritation.
It's important to wait at least 30 minutes after taking Fosamax before you consume food, beverages other than water, or other medications. This includes coffee, which can impede the absorption of the medication. Ensuring a sufficient time gap between taking Fosamax and drinking coffee maximizes the medication's absorption and efficacy.
The commonly prescribed dosage of Fosamax for the treatment of osteoporosis is 70 mg once weekly. Some patients may be prescribed a 10 mg daily dose based on their medical condition or doctor’s recommendation. It's crucial to strictly adhere to the dosage directions provided by your healthcare provider, as the appropriate dosage may vary depending on your medical history and response to treatment.
The duration for which one should continue taking Fosamax can vary greatly among individuals. Some patients may be advised to take it for several years, while others may use it for a short time. This decision is typically based on the patient's response to treatment, improvements in bone density, and potential risks associated with long-term use. It's important to have regular follow-ups with your healthcare provider to assess the need for continued Fosamax treatment. Treatment Duration & "Drug Holidays": Because Fosamax stays in the bone for many years, clinical guidelines now recommend a "drug holiday" (temporary discontinuation) for many patients. Doctors often suggest a holiday after 5 years of oral treatment, provided bone density is stable, and no fractures have occurred. Patients at very high risk for fractures may continue for up to 10 years before a holiday is considered. Continuous use beyond 5–10 years increases the risk of rare side effects like atypical femur fractures. Your doctor should reassess the need for continued treatment every 1–2 years using a DXA scan.
Uses & Mechanism of Action
Fosamax is primarily used to treat and prevent osteoporosis in postmenopausal women and men. It is also prescribed for treatment associated with the use of glucocorticoids, a class of steroid drugs that can cause bone loss. By increasing bone mass and strength, Fosamax helps reduce the risk of fractures, particularly hip and spine fractures.
Fosamax belongs to a class of medications known as bisphosphonates. It works by inhibiting osteoclasts, the cells that break down bone tissue. This action helps rebalance the bone remodeling process, favoring bone density maintenance and reducing bone turnover. By decreasing bone resorption, Fosamax increases overall bone mineral density, which is critical in managing and treating osteoporosis.
Fosamax plays a crucial role in managing osteoporosis by slowing down bone loss and increasing bone density. It works to prevent bone fractures by strengthening the skeleton. Its efficacy in reducing the risk of spine and hip fractures makes it a vital part of osteoporosis treatment plans, especially for individuals at high risk of fractures.
The effects of Fosamax on bone mineral density are not immediate and may take several months to become evident. Patients may begin to see stabilization or improvements in bone health within six months to a year of regular use. Regular monitoring by a healthcare provider helps track patient progress and ensures the effectiveness of the treatment through bone density scans.
Yes, Alendronate is the generic name for Fosamax. Both contain the same active ingredient and have the same efficacy in treating osteoporosis. The availability of a generic version offers a more cost-effective option for many patients, while still providing the same therapeutic benefits and safety profile.
Side Effects & Safety
Common side effects of Fosamax include gastrointestinal issues such as abdominal pain, acid reflux, constipation, and diarrhea. Some patients may also experience musculoskeletal pain, including joint, bone, or muscle discomfort. Although rare, serious side effects can include esophageal irritation, osteonecrosis of the jaw, and atypical femur fractures. Many patients tolerate Fosamax well, but it's crucial to promptly report any severe or persistent side effects to your healthcare provider.
While most individuals tolerate Fosamax without severe issues, there are potential serious side effects. These include osteonecrosis of the jaw, a condition characterized by the death of bone tissue in the jaw, and atypical femur fractures, which are rare but serious. Severe musculoskeletal pain may also occur, and any new or worsening symptoms should be discussed immediately with a healthcare professional.
Constipation is a known side effect of Fosamax. To help alleviate this, it is often recommended to increase fluid intake and dietary fiber. Regular exercise can also help. If constipation becomes problematic or persistent, discuss it with your healthcare provider for further management options or adjustments in therapy.
Joint pain is a potential side effect of Fosamax and may be more pronounced in some individuals. While it is typically mild to moderate, a healthcare provider should evaluate any severe or prolonged joint pain. It's important to address these symptoms early to adjust the treatment plan as necessary.
Interactions & Contraindications
Exercise is generally encouraged for individuals with osteoporosis as it helps improve bone health and overall fitness. However, it's best to avoid strenuous activity immediately after taking Fosamax to reduce the risk of gastrointestinal discomfort. It's safe to start your day with a gentle exercise routine, but consult your healthcare provider to create a personalized plan that accommodates your medication and physical abilities.
Calcium plays a critical role in bone health, and it's important to maintain adequate intake while taking Fosamax. Typically, the recommended daily intake ranges from 1,000 mg to 1,200 mg, based on dietary sources and supplements. It's advisable to take calcium supplements at a different time of day than Fosamax to ensure optimal absorption of both medications.
Hair loss is not commonly associated with Fosamax and is not listed as a primary side effect. If you notice unusual hair loss, it is wise to discuss this with your healthcare provider. There may be other causes of hair loss unrelated to Fosamax that need to be identified and addressed.
Fosamax can remain in your system for an extended period, even after discontinuation. The medication is incorporated into the bone matrix and can be detected for several years due to its long half-life in bone tissue. The exact duration can vary based on individual metabolism and bone turnover rates.
Fosamax is contraindicated in individuals with particular conditions, including abnormalities of the esophagus, such as stricture or achalasia, as well as those with low blood calcium levels (hypocalcemia) or those who cannot remain upright for at least 30 minutes after ingestion. It's essential to review your complete medical history with your healthcare provider to ensure Fosamax is a suitable therapy for you.
Generic & Alternatives
There are several alternatives to Fosamax for the management of osteoporosis, including other bisphosphonates like risedronate and ibandronate. Non-bisphosphonate options, such as denosumab (Prolia), and hormone-related therapies may also be considered, depending on the individual's medical history and risk factors. Consultation with a healthcare provider can help determine the most appropriate and safest treatment option for your condition.
Fosamax has not been taken off the market. However, concerns about its long-term safety and potential side effects, particularly esophageal cancer and severe musculoskeletal pain, have led to more cautious usage and recommendations for periodic review of treatment duration. Regular check-ups with your healthcare provider can help manage any risks associated with long-term usage.
Both Fosamax and Prolia have their own benefits and risks. The safety of each medication largely depends on individual patient factors such as medical history, risk of fractures, and specific drug tolerance. A healthcare provider can guide this choice by assessing these factors and identifying the appropriate option for effectively managing osteoporosis.
The cost of Fosamax can vary widely based on location, insurance coverage, and whether you choose the brand-name or generic option. Without insurance, the monthly cost of Fosamax can range from $100 to $300. Patients should explore pricing and insurance coverage options with their pharmacy or healthcare provider to manage costs effectively.
Fatigue is a less common side effect of Fosamax, but it can occur in some individuals. If you experience ongoing or significant tiredness that affects your daily activities, it is important to communicate this to your healthcare provider to determine the cause and decide whether adjustments to your treatment are needed.
For Medicare patients, the cost of Fosamax can be significantly reduced. Factors such as specific Medicare plan benefits, discounts, and the choice of the generic version of Alendronate can affect pricing. Patients should review their Medicare coverage and discuss it with their healthcare provider or pharmacist to accurately understand their out-of-pocket expenses.